Combination therapy and its resistance in the development of antimalarial drugs
Mercy O. Bamigboye·Favour K. Ejimofor·Miracle O. Obaleye·Joshua T. Olaifa·Wilfred I. Owoyemi·Oluwatoyin O. Ojo·Juliana B. Adetunji·Moriamo O. John·Ikechukwu P. Ejidike
Most cases of malaria, one of the most dangerous and common tropical parasite infections, occur in developing nations. Recent years have seen the emergence of novel treatment techniques, and numerous medication candidates are currently undergoing clinical research. One noteworthy outcome of combining an artemisinin derivative with a companion medication (in this case, mefloquine) using an alternative method of action is that it inhibits the growth of medication resistance and stops the spread of